Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,178 across all filing types
Latest filing 2024-04-05 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2024. It is addressed to stock exchanges and confirms the dematerialisation of securities and related compliance activities. The document is short (3650 characters) and primarily serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is a regulatory compliance certificate related to securities and share transfer agent activities. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2024-04-05 English
Intimation regarding loss of share certificate by the shareholder.
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the loss of share certificates and the stop transfer request from an investor. It is addressed to stock exchanges and signed by the company secretary. The document is short (2872 characters) and is a regulatory compliance communication rather than a financial report or announcement of voting results, management changes, or capital changes. It does not contain financial data or results, nor is it a report or presentation. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2024-04-04 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the loss of share certificates and the request for stop transfer. It is addressed to stock exchanges and signed by the company secretary. The document is short (2875 characters) and is a regulatory compliance communication rather than a financial report or announcement of financial results. It does not contain financial statements, earnings data, or management discussion. It is not an announcement of voting results, nor a report of director dealings or capital changes. It fits best under Regulatory Filings (RNS) as a compliance certificate filing under SEBI regulations.
2024-04-04 English
Lupin Appoints Dr. Ranjana Pathak as Chief Quality Officer.
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of Dr. Ranjana Pathak as Chief Quality Officer of Lupin Limited. It includes details about her background and the outgoing officer, as well as company information. There are no financial statements, quarterly or annual results, or detailed management discussion. The document is a formal announcement of a management change, specifically at the executive level. It references compliance with SEBI Listing Regulations for disclosure but does not contain financial data or report content. Therefore, it fits the category of Board/Management Information (MANG). The document length is about 5,049 characters, which is consistent with a detailed announcement rather than a full report or transcript.
2024-04-03 English
Press Release
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of Dr. Ranjana Pathak as Chief Quality Officer of Lupin Limited. It includes details about her background and the outgoing officer, as well as general company information. There are no financial statements, no detailed management discussion or analysis, no voting results, no regulatory certifications, or any other report-type content. The document is a corporate announcement about a management appointment, which fits the category of Board/Management Information (MANG). The document length is about 5,053 characters, which is sufficient for a detailed announcement but does not contain financial data or report content. Therefore, the correct classification is MANG with high confidence.
2024-04-03 English
Change in Management
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding changes in senior management, specifically the appointment of a new Chief Quality Officer and the retirement of the current President - Global Head of Quality. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including management changes. The content includes detailed information about the appointments and retirements, dates, and brief profiles, but does not contain financial data, earnings, or other report types. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2024-04-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.